目錄:MedChemExpress LLC>>生化試劑>> NGI-1 | MCE
參考價(jià) | ¥ 500 |
參考價(jià) | ¥ 500 |
更新時(shí)間:2023-06-19 09:16:24瀏覽次數(shù):92評(píng)價(jià)
聯(lián)系我們時(shí)請(qǐng)說(shuō)明是化工儀器網(wǎng)上看到的信息,,謝謝!
CAS | 790702-57-7 | 純度 | 99.90% |
---|---|---|---|
分子量 | 394.51 | 分子式 | C??H??N?O?S? |
供貨周期 | 現(xiàn)貨 | 規(guī)格 | 5 mg |
貨號(hào) | HY-117383 | 應(yīng)用領(lǐng)域 | 醫(yī)療衛(wèi)生,化工,生物產(chǎn)業(yè),制藥 |
MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報(bào),,我們不為任何個(gè)人用途提供產(chǎn)品和服務(wù),。
CAS No. : 790702-57-7
產(chǎn)品活性:NGI-1 (ML414) is a potent oligosaccharyltransferase (OST) inhibitor, directly targeting and blocking the function of the OST catalytic subunits STT3A and STT3B. NGI-1 is a cell permeable inhibitor and can effectively reduce virus infectivity without affecting cell viability.
研究領(lǐng)域:Anti-infection
作用靶點(diǎn):Virus Protease
In Vitro: NGI-1 inhibits the glycosylation of LASV GP mediated by STT3A-OST (in STT3B- and MAGT1-TUSC3- cells) or STT3B-OST (in STT3A- cells) and impaires its proteolytic cleavage in a dose-dependent manner.
NGI-1 blocks EGFR N-linked glycosylation in lung adenocarcinoma cells as assessed. In controls EGFR is biotinylated, consistent with its plasma membrane expression, but in NGI-1 treated cells the EGFR is predominantly found in the non-biotinylated intracellular fraction suggesting a change in cellular localization.
相關(guān)產(chǎn)品:Bioactive Compound Library Plus | Anti-Infection Compound Library | Anti-Cancer Compound Library | Antiviral Compound Library | Peptidomimetic Library | SRPIN340 | Aminothiazole | SP inhibitor 1 | Genkwanin | L-Lysine-15N2 (hydrochloride) | Aspirin-d4 | (-)-α-Pinene | 2'-Deoxy-2'-fluoro-l-uridine | LabMol-319 | 4E2RCat | HCVcc-IN-1 | ZIKV-IN-1 | HCVcc-IN-2 | Mpro inhibitor N3 | ESI-09 | Tubacin | 2-Phenylethanol-d9 | L-Lysine-13C6 (dihydrochloride) | Phenytoin | ML188 | N-Desmethylclozapine | DENV-IN-8 | ZIKV-IN-3 | Encephalitic alphavirus-IN-1 | Plerixafor octahydrochloride | 4-Phenylbutyric acid-d11 | SID-852843 | NS2B/NS3-IN-3 | (-)-Epicatechin gallate
熱門產(chǎn)品線:重組蛋白 | 化合物庫(kù) | 天然產(chǎn)物 | 熒光染料 | PROTAC | 同位素標(biāo)記物 | 寡核苷酸 | 抗體 | 點(diǎn)擊化學(xué)
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種*僅有化合物庫(kù),,我們致力于為*科研客戶提供前沿的高品質(zhì)小分子活性化合物;
• 50,000 多種高選擇性抑制劑,、激動(dòng)劑涉及各熱門信號(hào)通路及疾病領(lǐng),;
• 產(chǎn)品種類涵蓋各種重組蛋白,,多肽,,常用試劑盒 ,更有 PROTAC,、ADC 等特色產(chǎn)品,,廣泛應(yīng)用于新藥研發(fā)、生命科學(xué)等科研項(xiàng)目,;
• 提供虛擬篩選,,離子通道篩選,代謝組學(xué)分析檢測(cè)分析,,藥物篩選等專業(yè)技術(shù)服務(wù),;
• 設(shè)有專業(yè)的實(shí)驗(yàn)中心和嚴(yán)格的質(zhì)控、驗(yàn)證體系,;
• 提供 LC/MS,、NMR、HPLC,、手性分析,、元素分析等各項(xiàng)質(zhì)檢報(bào)告,確保產(chǎn)品的高純度,、高品質(zhì),;
• 產(chǎn)品的生物活性多經(jīng)各國(guó)客戶實(shí)驗(yàn)驗(yàn)證;
• Nature, Cell, Science 等多種頂級(jí)期刊及制藥 Patent 收錄了MCE客戶的科研成果,;
• 專業(yè)團(tuán)隊(duì)跟蹤最新的制藥及生命科學(xué)研究進(jìn)展,,為您提供*新的活性化合物;
• 與世界各大制藥公司及著名科研機(jī)構(gòu)建立了長(zhǎng)期的合作,。
(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)